期刊文献+

新辅助化疗FEC方案治疗妊娠期乳腺癌20例分析 被引量:2

An Analysis of Neoadjuvant Chemotherapy (FEC Regimen) for 20 Cases with Breast Cancer Associated with Pregnancy
下载PDF
导出
摘要 [目的]评估新辅助化疗FEC方案治疗妊娠期乳腺癌临床价值。[方法]对确诊的妊娠期乳腺癌20例行FEC方案化疗3~4个周期后,行手术治疗,手术后病理检查并做免疫组化检测ER、PR和C-erbB-2。[结果]经FEC方案新辅助化疗后,90%肿瘤原发灶明显缩小,15%完全缓解。腋窝淋巴结阳性率下降,33.3%完全缓解;ER、PR和C-erbB-2结果与新辅助化疗前不符合,不符合率分别为35%、25%、35%。[结论]在妊娠期乳腺癌采用FEC方案新辅助化疗可降低病期、争取保乳机会,筛选敏感的化疗药物,但也会影响术后病理结果,ER、PR和C-erbB-2也可能发生变化。
机构地区 徐州市中心医院
出处 《中国肿瘤》 CAS 2007年第7期575-576,共2页 China Cancer
  • 相关文献

参考文献7

二级参考文献34

  • 1Fisher B, Bryant J, Wolmark N, et al. Effect of pre-operative chemotherapy on the outcome of women with operable breast cancer[J]. J Clin Oncol, 1998, 16: 2672.
  • 2Mauriac L, Mac Grogan G, Avail A, et al. Neoadjuvant chemotherapy For operable breast carcinoma larger than 3 cm:A unicentre randomized trial with 124-month median follow-up[J]. Ann Oncol, 1999, 10: 47.
  • 3Broet P, Shcoll S M, De la Rochefordiere A, et al. Short and long term effects on survival in breast cancer patients treated by primary chemotherapy: An updated analysis of a randomized trial[J]. Breast Cancer Res Treat, 1999, 58: 151.
  • 4Bonadonna G, Valagussa P, Brambilla C, et al. Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute [ J ]. J Clin Oncol, 1998, 16 :93.
  • 5Jos A. van der Hage, Cornelis J H, van de Velde, et al. Preoperative chemotherapy in primary operable breast cancer: Results from the European organization for research and treatmentof cancer trial 10902 [J]. J Clin Oneol, 2001, 19:4224.
  • 6Cance W G, Carey L A, Calvo B F, et al. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma:effective clinical downstaging allows breast preservation and predicts outstanding local control and survival[J]. Ann Surg,2002, 236(3): 295.
  • 7Bonadonna G, Valagussa P, Brambilla C, et al. Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy[J]. Semin Oncol, 1991, 18(6):515.
  • 8Bhalla K, and Harris W B. Molecular and biologic determinants of neoadjuvant chemotherapy of locoregional breast cancer[J]. Semin Oneol, 1998, 25 suppl(3): 19.
  • 9Hutcheon A W, Heys S D, Miller I D, et al. Improvement in survival in patients receiving primary chemotherapy with docetaxel for breast cancer: a randomized controlled trial[J].Breast Cancer Res Treat, 2001, 69(3): 298.
  • 10曹月敏,乳腺外科学,1991年,323页

共引文献23

同被引文献40

  • 1王焱,康俊升,聂磊,何少武,乔峰.妊娠期乳腺癌的诊断与治疗[J].实用医药杂志,2007,24(1):36-36. 被引量:8
  • 2Wallack MK, Wolf JA, Bedwinek J, et al. Gestational carcinoma of the female breast[J]. Curt Probl Cancer, 1983,7(9) : 1- 58.
  • 3Ring AE, Smith IE, Jones A, et al. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals [ J]. J Clin Oncol, 2005, 23 ( 18 ) : 4192- 4197.
  • 4Ahn BY, Kim HH, Moon WK, et al. Pregnancy- and lactation- associated breast cancer: mammographic and sonographic findings[J]. J Ultrasound Med, 2003, 22(5) : 491-497.
  • 5Osei EK, Faulkner K. Fetal doses from radiological examinations [J]. Br J Radiol, 1999, 72(860): 773-780.
  • 6Petrek JA. Pregnancy safety after breast cancer[ J]. Cancer, 1994, 74( 1 suppl) : 528-531.
  • 7Berry DL, Theriault RL, Holmes FA, et al. Management of breast cancer during pregnancy using a standardized protocol [J]. J Clin Oncol, 1999, 17(3) : 855-861.
  • 8Gentilini O, Masullo M, Rotmensz N, et al. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options [J]. Eur J Surg Oncol, 2005, 31 (3): 232- 236.
  • 9Antypas C, Sandilos P, Kouvaris J, et al. Fetal dose evaluation during breast cancer radiotherapy [ J ]. Int J Radiat Oncol Biol Phys, 1998, 40(4) : 995-999.
  • 10Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy : a literature review[J]. Arch Surg, 2003, 138(1 ) : 91-98.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部